Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk
- PMID: 20067971
- PMCID: PMC2845052
- DOI: 10.2337/dc09-1825
Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk
Abstract
Objective: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function.
Research design and methods: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors.
Results: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52-3.95; P < 0.001) and cerebrovascular (1.63; 1.06-2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (R(s) = -0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI.
Conclusions: Our study suggests VAI is a valuable indicator of "visceral adipose function" and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Similar articles
-
LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.Endocr Pract. 2018 Jan;24(1):33-39. doi: 10.4158/EP-2017-0007. Epub 2017 Nov 16. Endocr Pract. 2018. PMID: 29144802
-
The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.Obesity (Silver Spring). 2013 Aug;21(8):1690-4. doi: 10.1002/oby.20096. Epub 2013 Apr 13. Obesity (Silver Spring). 2013. PMID: 23585246
-
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population.Lipids Health Dis. 2011 Oct 19;10:183. doi: 10.1186/1476-511X-10-183. Lipids Health Dis. 2011. PMID: 22011564 Free PMC article.
-
Body composition assessment for the definition of cardiometabolic risk.J Endocrinol Invest. 2013 Jul-Aug;36(7):537-43. doi: 10.3275/8943. Epub 2013 Apr 23. J Endocrinol Invest. 2013. PMID: 23612318 Review.
-
Visceral adiposity index: an indicator of adipose tissue dysfunction.Int J Endocrinol. 2014;2014:730827. doi: 10.1155/2014/730827. Epub 2014 Apr 14. Int J Endocrinol. 2014. PMID: 24829577 Free PMC article. Review.
Cited by
-
Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter.Int Braz J Urol. 2016 Sep-Oct;42(5):955-959. doi: 10.1590/S1677-5538.IBJU.2015.0396. Int Braz J Urol. 2016. PMID: 27532115 Free PMC article.
-
Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study.Cardiovasc Diabetol. 2022 Nov 1;21(1):225. doi: 10.1186/s12933-022-01670-x. Cardiovasc Diabetol. 2022. PMID: 36320060 Free PMC article.
-
Effect of defatted rice bran supplementation on metabolic parameters and inflammatory status in overweight/obese adults with hypercholesterolemia: a randomized, placebo-controlled intervention.BMC Nutr. 2022 Sep 1;8(1):94. doi: 10.1186/s40795-022-00586-9. BMC Nutr. 2022. PMID: 36045411 Free PMC article.
-
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria.Nutrients. 2023 Dec 18;15(24):5133. doi: 10.3390/nu15245133. Nutrients. 2023. PMID: 38140392 Free PMC article. Review.
-
Significantly increased visceral adiposity index in prehypertension.PLoS One. 2015 Apr 10;10(4):e0123414. doi: 10.1371/journal.pone.0123414. eCollection 2015. PLoS One. 2015. PMID: 25860643 Free PMC article.
References
-
- Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Després JP. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999;22:1471–1478 - PubMed
-
- Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy 2003;23:15–39 - PubMed
-
- DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925–932 - PubMed
-
- Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055–1058 - PubMed
-
- Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007;120(Suppl. 1):S12–S18 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical